Evidence-based diuretic therapy for improving cardiovascular prognosis in systemic hypertension. 2011

Firas J Al Badarin, and Mohammad A Abuannadi, and Carl J Lavie, and James H O'Keefe
Mid America Heart and Vascular Institute, Saint Luke's Hospital and University of Missouri-Kansas City, Kansas City, Missouri, USA.

Diuretics are among the most commonly prescribed cardiovascular (CV) medications. The strength of evidence supporting the effectiveness of diuretics in lowering blood pressure and for preventing major adverse CV events in patients with hypertension varies considerably among diuretic classes and even among agents within the same class. Unfortunately, common prescribing habits among American physicians, including specialists in CV diseases, are not in line with the existing evidence regarding diuretic therapy for improving CV prognosis. In conclusion, although hydrochlorothiazide is the standard diuretic used for hypertension, the outcomes data suggest that chlorthalidone, indapamide, and possibly even the aldosterone receptor blockers (spironolactone and eplerenone) may be superior agents.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival
D019317 Evidence-Based Medicine An approach of practicing medicine with the goal to improve and evaluate patient care. It requires the judicious integration of best research evidence with the patient's values to make decisions about medical care. This method is to help physicians make proper diagnosis, devise best testing plan, choose best treatment and methods of disease prevention, as well as develop guidelines for large groups of patients with the same disease. (from JAMA 296 (9), 2006) Medicine, Evidence-Based,Evidence Based Medicine,Medicine, Evidence Based

Related Publications

Firas J Al Badarin, and Mohammad A Abuannadi, and Carl J Lavie, and James H O'Keefe
January 1987, The American journal of medicine,
Firas J Al Badarin, and Mohammad A Abuannadi, and Carl J Lavie, and James H O'Keefe
December 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
Firas J Al Badarin, and Mohammad A Abuannadi, and Carl J Lavie, and James H O'Keefe
January 1978, Archivos del Instituto de Cardiologia de Mexico,
Firas J Al Badarin, and Mohammad A Abuannadi, and Carl J Lavie, and James H O'Keefe
January 2011, Cardiovascular journal of Africa,
Firas J Al Badarin, and Mohammad A Abuannadi, and Carl J Lavie, and James H O'Keefe
February 2021, Journal of the American College of Cardiology,
Firas J Al Badarin, and Mohammad A Abuannadi, and Carl J Lavie, and James H O'Keefe
April 1975, Pennsylvania medicine,
Firas J Al Badarin, and Mohammad A Abuannadi, and Carl J Lavie, and James H O'Keefe
January 2005, ACP journal club,
Firas J Al Badarin, and Mohammad A Abuannadi, and Carl J Lavie, and James H O'Keefe
November 1989, The American journal of cardiology,
Firas J Al Badarin, and Mohammad A Abuannadi, and Carl J Lavie, and James H O'Keefe
January 1986, Clinical therapeutics,
Firas J Al Badarin, and Mohammad A Abuannadi, and Carl J Lavie, and James H O'Keefe
January 1986, Drugs,
Copied contents to your clipboard!